Application 214588
- Type
- ANDA
- Sponsor
- ALEMBIC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | SOLUTION/DROPS;OPHTHALMIC | 1.5% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214588-001 | BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2023-04-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214588-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214588-001 | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2023-04-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214588-001 | AT | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bepotastine Besilate Ophthalmic Solution 1.5% | BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% | Alembic Pharmaceuticals Inc. | f68306a9-80ec-4bc5-8c00-1e1328f21e36 | 2023-07-21 | Warnings, Adverse reactions | 214588 ANDA214588 |
| Bepotastine Besilate Ophthalmic Solution 1.5% | BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% | Alembic Pharmaceuticals Limited | de111d74-c740-47b3-adc7-4b855df2c561 | 2023-07-21 | Warnings, Adverse reactions | 214588 ANDA214588 |